Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
0.8600
-0.0610 (-6.62%)
Nov 20, 2025, 11:12 AM EST
Interpace Biosciences Market Cap
Interpace Biosciences has a market cap or net worth of $3.81 million as of November 21, 2025. Its market cap has decreased by -57.76% in one year.
Market Cap
3.81M
Enterprise Value
4.65M
Revenue
41.92M
Ranking
n/a
PE Ratio
7.93
Stock Price
$0.86
Market Cap Chart
Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 3.81M, a decrease of -98.28%. That is a compound annual growth rate of -13.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 3.81M | -67.92% |
| Dec 31, 2024 | 11.87M | 152.98% |
| Dec 29, 2023 | 4.69M | 5.76% |
| Dec 30, 2022 | 4.44M | -85.77% |
| Dec 31, 2021 | 31.18M | 145.72% |
| Dec 31, 2020 | 12.69M | -33.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 554.98M |
| Glass House Brands | 520.88M |
| Tian'an Technology Group | 386.45M |
| CytoDyn | 384.62M |
| Northwest Biotherapeutics | 382.71M |
| American Oncology Network | 346.66M |
| Nika Pharmaceuticals | 311.89M |